 Boca Raton, FL, Sept. 27, 2021 GLOBE NEWSWIRE -- INmune Bio, Inc. NASDAQ: INMB the, Company, a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, today announced that Mark Lowdell, PhD, Chief Scientific Officer and Chief Medical Officer, will be participating in an oncology panel at the B. Riley Fall 2021 Best Ideas in Oncology Series. 